Recently, Zhao and collaborators demonstrated that TRAF-interacting protein with forkhead-associated domain B (TIFAB), a direct target gene of RelB overexpressed in human AML and correlated with poor prognosis, upregulates HOXA9, thus promoting MLL-AF9 AML in vivo. The gene discussed is TIFAB; the disease is acute myeloid leukemia.